Global Innovative Platforms GIPL
OTC GIPL
$0.50 +0.00 (+0.00%)
At close: Oct 20, 2026 · 4:00 PM EDT

Global Innovative Platforms (GIPL) Cash & Equivalents (2021 - 2026)

Updated

Global Innovative Platforms (GIPL) recorded Cash & Equivalents of $244,235 in fiscal Q3 2026 (quarter ended Jun 30, 2026), down 25.4% from the prior quarter.

Analysis

Global Innovative Platforms (GIPL) Cash & Equivalents (2021 - 2026) Analysis & Trends

At the end of FY2025 (ended Sep 30, 2025), Global Innovative Platforms reported Cash & Equivalents of $17,828.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 16.91 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 6.57 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn 6.85 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 7.62 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 4.90 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 976.00 Mn
10 Global Innovative Platforms 24.88 Mn 24.27 Mn - 244,235.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 244,235.00
Mar 31, 2026 327,270.00
Sep 30, 2025 17,828.00
Jun 30, 2021 18,500.00
API Access

Global Innovative Platforms Cash & Equivalents API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=GIPL&period=max&api_key=YOUR_API_KEY